Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03905681 · ClinicalTrials.gov registry record · NA
TENS Efficacy on Acute Back Pain in an Emergency Department Triage
A NA study of Acute Back Injury, sponsored by William Beaumont Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03905681: Completed NA study of Acute Back Injury, sponsored by William Beaumont Army Medical Center.
NCT03905681 is a NA study of Acute Back Injury that has completed, run by William Beaumont Army Medical Center. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03905681, a NA study of Acute Back Injury, has completed, sponsored by William Beaumont Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Transcutaneous Electrical Nerve Stimulation (TENS) devices produce a gentle electrical stimulation that when applied through pads applied directly to the skin, has a noticeable effect in reducing pain associated with various types of injuries and ailments. Several recent studies have shown efficacy when used for acute pain specific to primary dysmenorrhea, renal colic, lower-extremity pain, and pain associated with spinal cord injury, and was achieved without adverse effects. This study is intended to compare the effects of TENS units on acute back pain on ambulatory patients who are awaiting emergency medical treatment, to uncover if a statistically-significant analgesic effect is noted compared to a placebo device.
Primary Outcome
Enrolled participants will have baseline Visual Analogue Scores (VAS) pain scale scores assessed, consisting of a 0 to 100 unit scale, with instruction to locate their level of pain on the scale of 0 being "No pain at all," 50 being "Moderate Pain," and 100 being "Worst pain imaginable," and will be compared to score on the same scale after treatment.
Conditions Studied
Interventions
- DEVICE Transcutaneous Electrical Nerve Stimulation
Study Locations (1)
Texas
- William Beaumont Army Medical Center - Fort Bliss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-04-02 |
| Est. Completion | 2019-05-16 |
| Phase | NA |
What the finished NCT03905681 record still lists
NCT03905681 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Acute Back Injury appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Electrical Nerve Stimulation is the first listed.
NCT03905681 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03905681 about?
NCT03905681 is a clinical study titled "TENS Efficacy on Acute Back Pain in an Emergency Department Triage". Transcutaneous Electrical Nerve Stimulation (TENS) devices produce a gentle electrical stimulation that when applied through pads applied directly to the skin, has a noticeable effect in reducing pain associated with various types of injuries and ailments. Several recent studies have shown efficacy ...
What is the current status of trial NCT03905681?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-04-02. Estimated completion is 2019-05-16.
What conditions does trial NCT03905681 study?
This clinical trial studies the following conditions: Acute Back Injury.
What interventions are being tested in trial NCT03905681?
The interventions under investigation include: Transcutaneous Electrical Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03905681?
This trial is sponsored by William Beaumont Army Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03905681 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03905681's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI